Recent Updates — CURLF

Curaleaf Holdings reported third-quarter net revenue of $352.7 million, an 11% increase from the prior-year period, driven by growth in both domestic and international segments. Adjusted EBITDA reached $77.6 million with a margin of 22.0%, while adjusted gross profit margin stood at 48.7%. The company posted a net loss of $37.4 million from continuing operations but generated $22 million in cash flow from continuing operations. Curaleaf ended the quarter with $105 million in cash and is evaluating an alternative merger transaction for Aurora Cannabis following its own original offer.

The Compensation Committee and Board approved new compensation arrangements for Chairman and CEO Boris Jordan effective September 28, 2026. The changes include increasing his target short-term incentive opportunity from 125% to 200% of base salary for 2027. Additionally, he received a discretionary $1 million bonus tied to strategic targets, payable in March 2028, and a one-time grant of 1,344,275 time-based restricted stock units valued at approximately $15.4 million, vesting fully on January 5, 2028. Curaleaf Holdings operates as a cannabis cultivation, processing, and retail company in the United States.

Curaleaf Holdings, Inc. announced the opening of a new dispensary in Edgewater, Florida, on July 17, 2026. This expansion increases the company's Florida retail footprint to 74 locations and its total nationwide store count to 166. Curaleaf is an international provider of consumer cannabis products.